Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-03-27
1997-02-11
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544265, 5483265, A61K 3152, C07D47330, C07D23390
Patent
active
056021402
ABSTRACT:
Purine derivatives shown by general formula [I] or pharmacologically acceptable salts thereof. Suppressants for inflammatory diseases containing an effective ingredient of said purine derivative. ##STR1## (wherein, R represents one group selected from the groups composed of H atom, a straight chain alkyl group having 1-10 carbon atoms, a branched chain alkyl group having 3-10 carbon atoms, an alkyl group having 1-10 carbon atoms substituted with one carboxyl group, 4-carboxybenzyl group and phenethyl group).
Above mentioned purine derivatives prevent the tissue damages due to mediators such as active oxygen and TXA.sub.2 in the initial stage of inflammation, and prevent the subsequent aggravation of inflammatory responses due to the adhesion of activated leukocytes to the cells in the lesion, and exhibit efficacy as anti-inflammatory drugs in all stages of inflammatory diseases caused by leukocytes.
REFERENCES:
patent: 4578460 (1986-03-01), Francia
patent: 4728644 (1988-03-01), Imayoshi et al.
patent: 4772606 (1988-09-01), Sircar et al.
patent: 4885301 (1989-12-01), Coates
patent: 4975467 (1990-12-01), Ku et al.
patent: 5073559 (1991-12-01), Coates
patent: 5098906 (1992-03-01), Sircar et al.
patent: 5250534 (1993-10-01), Bell et al.
patent: 5270465 (1993-12-01), Ferrand et al.
patent: 5272153 (1993-12-01), Mandell et al.
Ohsaki, Chem. Pharm. Bull. 34, 36 (1986).
Broughton et al. (1975), "Antiallergic Acivity of 2-Phenyl-8-Asapurin-6-Ones," 18 J. Med. Chem. 11:1117-1122.
Iizuka, K. et al. "Highly Selective Inhibitors of Thromboxane Synthetase!. Imidazole Derivatives" J. Med. Chem., vol. 24, No. 10, pp. 1139-1148, 1981.
Morita, K. et al. "Ozagrel Hydrochloride Monohydrate, a Thromboxane Synthase Inhibitor, and Its Metabolites of Hepatic Microsomal Drug Metabolism" Chem. Pharm. Bull, vol. 7, No. 12, pp. 3351-3354, Dec. 1989.
Chiba Nobuyoshi
Goto Yuso
Isobe Yoshiaki
Sato Hideharu
Berch Mark L.
Japan Energy Corporation
LandOfFree
Purine derivatives and suppressants for inflammatory diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Purine derivatives and suppressants for inflammatory diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purine derivatives and suppressants for inflammatory diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-342382